Investor Information

News

Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2024

View News

Summit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024

View News

More Information

Share Price

NASDAQ: SMMT

4.44 USD

17-May-2024 16:00 UTC-4

More Information

SEC Filings

Current report filing

View News

Prospectus filed pursuant to Rule 424(b)(5)

View News

More Information

Email Alerts